Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Viralgen Vector Core
San Sebastián, Spain
A
51-100 Employees
2017
Key takeaway
Viralgen, a key player in the gene therapy landscape, focuses on the industrial production of AAV for clinical trials, positioning itself as an emerging leader in the field. With a commitment to meeting regulatory standards and recent expansions for commercial manufacturing, Viralgen is well-equipped to support the growing demand for gene therapy.
Reference
Core business
Viralgen - Home
Tyris tx
Paterna, Spain
A
1-10 Employees
-
Key takeaway
Tyris is focused on advancing non-viral gene therapies, aiming to provide safer and more controllable treatment options for various diseases. Their innovative platform enhances DNA-based therapies, making them more effective for a wide range of genetic conditions.
Reference
Core business
Tyris Tx - Enhancing DNA-based therapies further ahead
A groundbreaking platform that extends the reach of genetic treatments by combining unprecedented DNA optimisation with non-viral delivery.
Integra Therapeutics
Barcelona, Spain
A
1-10 Employees
2020
Key takeaway
Integra Therapeutics is focused on developing next-generation gene writing tools that enhance the efficiency and safety of advanced therapies, which is crucial for in vivo gene therapy applications. Their commitment to addressing the limitations of current gene writing technologies aligns with the need for innovative solutions in treating genetic and oncological diseases.
Reference
Core business
Company - Integra therapeutics
COMPANY Expertise ingene writing Integra Therapeutics is a biotech company that is creating next-generation gene writing tools to boost the efficiency and safety of advanced therapies. Advanced therapies are a pillar of the medicine of the future. Our lead technology is FiCAT, a best-in-class platform geared towards resolving the current limitations on gene writing: size, […]
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
TraffikGene
Santiago de Compostela, Spain
A
1-10 Employees
2023
Key takeaway
The company is focused on advancing in vivo gene therapy through its innovative peptide-based gene delivery platform, TraffikGene. This proprietary technology enhances the efficient and safe delivery of nucleic acid therapeutics to their intended sites of action.
Reference
Product
Technology | TraffikGene
TraffikGene is a business initiative devoted to the development of disruptive gene delivery non-viral vectors.
TAAV Biomanufacturing Solutions
San Sebastián, Spain
A
51-100 Employees
2019
Key takeaway
TAAV Biomanufacturing Solutions is a dedicated Contract Development Manufacturing Organization (CDMO) that specializes in producing neDNA™, an enzymatic DNA alternative to plasmid DNA, for the manufacture of recombinant adeno-associated virus (rAAV). Their commitment to gene therapy and collaboration with biopharma companies and research centers positions them as key players in the development of AAV-based gene therapies.
Reference
Core business
Committed to the power of gene therapy - TAAV Who we are
Committed to the power of gene therapy. Discover neDNA™, an enzymatic alternative to plasmid DNA for the manufacture of rAAV
Fagron Genomics
Terrassa, Spain
A
11-50 Employees
2018
Key takeaway
Fagron Genomics specializes in developing medical genetic algorithms that enhance understanding of individual genetic profiles, which can inform personalized treatment strategies. Their approach emphasizes the role of genetics in tailoring therapies to improve therapeutic outcomes.
Reference
Core business
Fagron Genomics
Home
TETRANEURON
Madrid, Spain
A
1-10 Employees
2012
Key takeaway
Tetraneuron is pioneering innovative gene therapies for neurodegenerative diseases, particularly focusing on Alzheimer’s disease through a unique mechanism of action. With a scientific team boasting over 30 years of expertise in neuroscience, Tetraneuron is positioned to make a transformative impact on brain health.
Reference
Core business
About us – Tetraneuron
Algenex
Pozuelo de Alarcón, Spain
A
1-10 Employees
2005
Key takeaway
Algenex is a biotechnology company that specializes in the production of recombinant proteins, including antigens and growth factors, using its proprietary Baculovirus vector expression systems. This innovative approach enhances the availability of biologics, which is crucial for advancements in areas like gene therapy.
Reference
Core business
Algenex, european biotech. Transforming protein production.
Algenex is a private biotech company with proprietary and patented technologies to boost the production of recombinant proteins using BVES in insect cells.
Emerald Health Biotechnology España S.L.U (formely Vivacell Biotechnology España S.L.U)
Córdoba, Spain
A
11-50 Employees
2003
Key takeaway
VivaCell Biotechnology España SLU is a clinical stage Pharma Biotech company focused on discovering and developing innovative drug candidates for serious medical conditions.
Reference
Core business
Vivacell Biotechnology España
Biohope
Tres Cantos, Spain
A
11-50 Employees
2015
Key takeaway
Biohope Scientific Solutions for Human Health SL is focused on the commercialization of proprietary technologies and the development of new products. Their lead product, Immunobiogram®, is a patented in vitro diagnostic platform that optimizes immunosuppressive therapy, showcasing their commitment to advancing personalized medicine through innovative approaches.
Reference
Core business
Corporate - Biohope
The Biohope Group is composed by two companies: Biohope Scientific Solutions for human health SL and Biohope Research SL.
Technologies which have been searched by others and may be interesting for you:
When exploring the In Vivo Gene Therapy industry in Spain, several key considerations come into play. Regulatory frameworks are crucial, as Spain adheres to the European Medicines Agency (EMA) guidelines, which govern clinical trials and product approvals. Understanding these regulations is essential for compliance and successful market entry. The competitive landscape is evolving, with both established pharmaceutical companies and innovative startups actively engaging in gene therapy research and development. This creates opportunities for collaboration and investment, particularly in regions with strong biotech hubs like Catalonia and Madrid. Challenges include high development costs and the complexity of manufacturing gene therapies, which requires specialized facilities and expertise. Environmental concerns also arise, particularly regarding the safety of gene-modified organisms and their long-term impact on ecosystems. Furthermore, Spain's position within the broader European and global markets presents unique opportunities, given the increasing demand for advanced therapeutic solutions. Networking with local biotech associations and attending industry events can provide valuable insights and connections. Overall, a comprehensive understanding of the regulatory landscape, market dynamics, and environmental implications is essential for anyone looking to engage with the In Vivo Gene Therapy sector in Spain.
Some interesting numbers and facts about your company results for In Vivo Gene Therapy
| Country with most fitting companies | Spain |
| Amount of fitting manufacturers | 206 |
| Amount of suitable service providers | 171 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2003 |
| Youngest suiting company | 2023 |
Some interesting questions that has been asked about the results you have just received for In Vivo Gene Therapy
What are related technologies to In Vivo Gene Therapy?
Based on our calculations related technologies to In Vivo Gene Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of In Vivo Gene Therapy?
Start-Ups who are working in In Vivo Gene Therapy are TraffikGene
Which industries are mostly working on In Vivo Gene Therapy?
The most represented industries which are working in In Vivo Gene Therapy are Biotechnology, Healthcare, Pharmaceuticals, Other, Medical
How does ensun find these In Vivo Gene Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.